aTen Therapeutics Overview

  • Year Founded
  • 2005

Year Founded

  • Status
  • Private

  • Employees
  • 4

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 1

aTen Therapeutics General Information

Description

Developer of novel therapeutic antibodies designed to offer treatment for major diseases. The company's antibodies block cancer cell growth, invasion, and metastasis in a variety of tumor models with the help of anti-cancer agents for cancer cell proliferation, tumor invasion, and metastasis, enabling doctors to improve the lives of people with cancer and protect against developing metastases.

Contact Information

Formerly Known As
Onco biopharm, Dunwilco (1277), Nucana, Nucana Biopharmaceuticals
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1 Lochrin Square
  • Fountainbridge
  • Edinburgh EH3 9QA
  • Scotland, United Kingdom
+44 0131
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Vertical(s)
Corporate Office
  • 1 Lochrin Square
  • Fountainbridge
  • Edinburgh EH3 9QA
  • Scotland, United Kingdom
+44 0131

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

aTen Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Secondary Transaction - Private 11-Jul-2024 Completed Generating Revenue
6. Later Stage VC Completed Generating Revenue
5. Grant 01-May-2022 Completed Generating Revenue
4. Secondary Transaction - Private Completed Generating Revenue
3. Later Stage VC 31-Mar-2017 Completed Generating Revenue
2. Grant 01-May-2016 $143K $429K Completed Generating Revenue
1. Angel (individual) 16-Aug-2007 $429K $429K Completed Startup
To view aTen Therapeutics’s complete valuation and funding history, request access »

aTen Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
Ordinary
To view aTen Therapeutics’s complete cap table history, request access »

aTen Therapeutics Patents

aTen Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202414714-D0 Antibody and its medical uses Inactive 07-Oct-2024
GB-202414702-D0 Therapeutic use of antibody Inactive 07-Oct-2024
GB-202216202-D0 Antibody and its medical uses Inactive 01-Nov-2022
GB-202216204-D0 Therapeutic use of antibody Inactive 01-Nov-2022
GB-202206195-D0 Antibody Inactive 28-Apr-2022
To view aTen Therapeutics’s complete patent history, request access »

aTen Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

aTen Therapeutics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Innovate UK Government
To view aTen Therapeutics’s complete investors history, request access »

aTen Therapeutics FAQs

  • When was aTen Therapeutics founded?

    aTen Therapeutics was founded in 2005.

  • Where is aTen Therapeutics headquartered?

    aTen Therapeutics is headquartered in Edinburgh, United Kingdom.

  • What is the size of aTen Therapeutics?

    aTen Therapeutics has 4 total employees.

  • What industry is aTen Therapeutics in?

    aTen Therapeutics’s primary industry is Biotechnology.

  • Is aTen Therapeutics a private or public company?

    aTen Therapeutics is a Private company.

  • What is aTen Therapeutics’s current revenue?

    The current revenue for aTen Therapeutics is .

  • How much funding has aTen Therapeutics raised over time?

    aTen Therapeutics has raised $2.09M.

  • Who are aTen Therapeutics’s investors?

    Innovate UK has invested in aTen Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process